The AI moat
is not code.
It's invention.
Gargantua Labs discovers novel primitives inside frontier language models, patents them at the USPTO before public disclosure, and licenses the IP to the companies that need it. Twenty-five claims filed. Five model families replicated. A live product, DeltaWrite, already inside the portfolio.
Three shifts make IP the last durable moat in AI.
Agentic coding is collapsing the cost of building software. Model weights are becoming commodity. What stays scarce — and defensible — is the primitive underneath: the mechanism itself, filed and owned.
Code is free. Invention is not.
Every AI-native startup is now a clone target. The primitive underneath — the closed-form slot build, the dispatch geometry — can't be vibe-coded. We file before disclosure and the priority date locks the world out.
Weights churn quarterly. Patents run twenty years.
A fine-tune is obsolete the day GPT-6 ships. A granted patent compounds across every model that replicates the capability — Qwen, Llama, Mistral, whatever comes next. Our assets get more valuable as the ecosystem scales.
The foundation labs are our distribution.
Every enterprise running an LLM is a potential licensee. We don't sell hosting. We don't need a go-to-market army. Open-source and frontier families do the scaling; we collect on the mechanism.
Write new knowledge into a frozen model. In one forward pass.
Not fine-tuning. Not RAG. Not in-context. DeltaWrite installs a fact directly into the weight matrix with no gradient computation — and it survives across prompts, sessions, and model reloads. Click a question. Watch the base model fail. Inject. Watch it answer.
The primitive that shouldn't exist.
Rank-1 perturbation to a single projection matrix, built from a closed-form forward pass. No backprop. No training loop. Under oracle dispatch we hit 100% recall across 500 facts with zero control leaks. On paraphrased queries, end-to-end: 94%.
- Model
- Qwen2.5-7B-Instruct (frozen)
- Layer
- 27 · mlp.down_proj
- Write cost
- ~112 ms · one forward pass
- Persistence
- Cross-session, serialisable, reversible
- Patent
- USPTO · filed 2026-04-11 · 25 claims
Numbers we will show under NDA.
Every figure here is reproducible from the research repo. All ablations, seeds, and control prompts are pre-registered. Full protocol available to qualified investors.
The IP window closes once everyone sees it.
“In a world where anyone can build anything, the only thing left to own is the underlying invention — and the claims that surround it.”
— Founding thesis, Gargantua Labs
Why this compounds where fine-tunes don't.
Every license pays for the next filing. Every filing widens the moat.
Each license funds the next invention. Each new invention is a separable asset. Each new asset widens the claim surface. Investors buy into the flywheel, not any single patent.
Invent. Patent. License. Repeat.
Three steps. Replicable cadence. A clear revenue moment at step three.
Invent
We look at frontier models the way a mechanical engineer looks at a gearbox. We find the primitive nobody has filed on. We prove it generalises across model families before we move.
Patent
We file provisional before any public disclosure. The claim drafts cover the primitive, the mechanism, and the system-level use. Non-provisional conversion locks in 20-year enforceability.
License
We license the IP — non-exclusive, exclusive, or field-of-use. The base model stays neutral. Licensees run deployments inside their own stack, with their own data, under their own compliance.
A small lab. By design.
Invention density per headcount is the metric we optimise. We keep the team small, the scope narrow, and the output legible.
Nathan Peterson
Sole inventor on the current filings. Background in mechanistic interpretability and applied transformer research. Runs the invention cadence.
Patent Counsel
Senior-partner-led drafting and prosecution. Specialises in software and ML claim strategy. Engaged on all active and planned filings.
Research hire #2
Reserved for a post-seed technical hire focused on the next primitive in the pipeline. Full profile shared with committed investors.
The questions every VC asks.
Invest in the lab.
Or license the IP.
Capital raise is live. Licensing slate opens Q3. We're prioritising a short list this quarter; first meetings order the cap table and the licensee queue. Whichever side you're on, the first step is a private one — NDA standard.